BOLDpharma is an initiative launched earlier this year by digital agency Anthill, together with key industry figures, to address the lack of confidence the industry has sometimes shown, and which makes it hard to launch "big ideas that create real change". The initiative is designed "to be the thought provocation that our industry needs, and to inspire and build a community of like-minded individuals to encourage innovation in pharma – confident, challenging, bold-thinking people who will drive the industry’s development in the years to come", says the agency.
One of the initial calls to action is the BOLD Survey, which has just been launched to uncover precisely what is holding people back. Initial results highlight the great potential for the industry to work in new ways – but there needs to be action. 89% of respondents believed that their organization is not fully-utilizing the technology at their disposal and less than 20% believed that an innovative initiative would be supported within their organization.
"This movement has the potential to drastically improve the state of healthcare. There’s strength in numbers and the BOLD movement has already begun highlighting that the numbers are on the side of pro-active change," says Anthill.
To be part of the BOLDpharma initiative, follow this link to take part in the survey and receive a personal profile in relation to some key BOLD metrics. Further information can be found on Twitter, @BOLDpharma and the BOLDPharma website.
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.